Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.

Abstract

OBJECTIVE To evaluate facility-level variation in prescription rates of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) medications for patients with diabetes mellitus (DM) and chronic kidney disease (CKD). STUDY DESIGN Retrospective database analysis from 143 Veterans Health Administration facilities. METHODS… (More)

Topics

  • Presentations referencing similar topics